info-icon

Your Q-global and Q-interactive Login is changing, find out more here.

info-icon

WAIS-5 UK Coming in Late 2026! Learn more and Pre-order today

alert-icon

${loserAccounts} been merged into ${winnerAccount}.

A recent audit found these accounts to be duplicative. Addresses, order history and Q-global ordering for both accounts are now accessible via the ${winnerAccount} account. If something isn’t right, contact us.

alert-icon

${loserAccounts} been merged into ${winnerAccount}.

A recent audit found these accounts to be duplicative. Addresses, qualified users, order history and Q-global ordering for both organisations are now accessible via the ${winnerAccount} account. If something isn’t right, contact us.

As of March 3rd, 2025, Mapi Research Trust will manage all licensing and distribution requests for the Positive and Negative Syndrome Scale (PANSS). For more information, please see below.  
Positive and Negative Syndrome Scale
Activate to view the image in zoom mode

Positive and Negative Syndrome Scale

PANSS

Stanley R. Kay, PhD,Lewis A. Opler, MD,Abraham Fiszbein, MD
As of March 3rd, 2025, Mapi Research Trust will manage all licensing and distribution requests for the Positive and Negative Syndrome Scale (PANSS). For more information, please see below.  

As of March 3rd, 2025, all licensing and distribution requests for the Positive and Negative Syndrome Scale (PANSS) will be managed by Mapi Research Trust.

Requesting Permission to Use PANSS

To request permission, please contact Mapi Research Trust through the ePROVIDE™ platform.

How to Submit a Request

Submitting a request is free of charge and ensures an optimised service. It does not commit you to purchasing any material.

  1. Go to Submit a Request
  2. If you haven’t registered yet, you’ll be asked to sign up for free.
  3. Complete the request form and attach any necessary documents.

For guidance, refer to this tutorial.

Ongoing Clinical Research Trials

For customers involved in ongoing Clinical Research Trials, please contact us here for continued support.